| Q33427799 | A novel immune evasion strategy of candida albicans: proteolytic cleavage of a salivary antimicrobial peptide |
| Q35563978 | Antimicrobial peptides in defence of the oral and respiratory tracts |
| Q34684398 | Antimicrobial peptides in the oral environment: expression and function in health and disease. |
| Q39472812 | Candida albicans mutants deficient in respiration are resistant to the small cationic salivary antimicrobial peptide histatin 5. |
| Q73930216 | Effect of donor age on the concentrations of histatins in human parotid and submandibular/sublingual saliva |
| Q33997988 | Further characterization of human salivary anticandidal activities in a human immunodeficiency virus-positive cohort by use of microassays. |
| Q37131510 | Host defense peptides in the oral cavity |
| Q44006227 | Inhibitory effect of synthetic histatin 5 on leukotoxin from Actinobacillus actinomycetemcomitans |
| Q54016398 | Prevalence of potential respiratory pathogens in the mouths of elderly patients and effects of professional oral care. |
| Q43480165 | Relationship between oral motor dysfunction and oral bacteria in bedridden elderly |
| Q43736230 | Salivary anticandidal activity and saliva composition in an HIV-infected cohort |
| Q33980976 | Salivary histatin 5 and human neutrophil defensin 1 kill Candida albicans via shared pathways. |
| Q24548705 | Salivary histatin 5 is an inhibitor of both host and bacterial enzymes implicated in periodontal disease |
| Q34722920 | Susceptibility of Candida dubliniensis to salivary histatin 3. |